A Comparative Study To Assess the Effectiveness of INDIVIDUALIZED HOMOEOPATHIC MEDICINES VIS A VIS PATHOLOGICAL SIMILE in Cases of Migraine using MIDAS TOOL
试验速览
- 阶段
- Phase 3 4
- 状态
- 尚未招募
- 发起方
- 入组人数
- 80
- 试验地点
- 1
- 主要终点
- According to the scores obtained (pre
研究概览
简要总结
This study is prospective, randomized, parallel arm, interventional study to evaluate the role of homoeopathic medicines in cases of migraine.The primary outcome measures will be According to the scores obtained (pre
and post treatment) from the (MIDAS) Migraine Disability Assessment Test. The Secondary outcome is to assess the effectiveness of ’Individualized Homoeopathic Medicines’ vis a vis ’Pathological Simile’ in cases of Migraine using (MIDAS)Migraine Disability Assessment test.
Null Hypothesis (H0) – There is no significant difference in improvement in cases of Migraine treated with homoeopathic medicines selected on basis of totality of symptoms vis a vis pathological simile selected on basis of Hughes concept of specific similarity
AlternateHypothesis (H1) –There is a significant difference in improvement in cases of Migraine treated with homoeopathic medicines selected on basis of totality of symptoms vis a vis pathological simile selected on basis of Hughes concept of specific similarity
研究设计
- 研究类型
- Interventional
- 分配方式
- Computer generated randomization
- 盲法
- Not Applicable
入排标准
- 年龄范围
- 18.00 Year(s) 至 50.00 Year(s)（—）
- 性别
- All
入选标准
- •1.Patients of both sexes 2.Patients giving volunatary consent for the study 3.Cases of Migraine diagnosed according to ICHD criteria.
排除标准
- •1.Cases who refuse to give informed consent for the study 2.Cases with any other severe systemic disorder with advanced pathological conditions 3.Co-morbidities other than migraine 4.Pregnant and lactating women 5.Patients suffering from autoimmune diseases, HIV, etc 6.Patient pursuing other treatment and are not willing to leave it 7.Complications of migraine (according to ICHD).
结局指标
主要结局
According to the scores obtained (pre
时间窗: Pre scores will be taken at baseline of treatment and | post scores will be assessed at the end of 12 weeks using | MIDAS (Migraine Disability Assessment Test)
and post treatment) from the MIDAS (Migraine Disability Assessment Test)
时间窗: Pre scores will be taken at baseline of treatment and | post scores will be assessed at the end of 12 weeks using | MIDAS (Migraine Disability Assessment Test)
次要结局
- To compare the treatment response in cases of Migraine treated with ‘Individualized Homoeopathic medicines selected on basis of Totality of symptoms’ vis a vis ‘Pathological simile selected on basis of specific similarity by Richard Hughes’ using MIDAS tool